Trials / Terminated
TerminatedNCT02414776
Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
Phase Ib/II Study of Hydroxychloroquine in Metastatic ER-Positive Breast Cancer Progressing on Hormonal Therapy
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Western Regional Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety and tolerability of orally administered hydroxychloroquine with hormonal therapy. To assess the response rate of hydroxychloroquine in combination with hormonal therapy.
Detailed description
To determine the number of patients with adverse effects To assess the clinical response to the combination
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | hydroxychloroquine | administration of hydroxychloroquine in combination with the current hormonal therapy |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-04-13
- Last updated
- 2017-09-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02414776. Inclusion in this directory is not an endorsement.